Literature DB >> 10505726

Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.

A B Thomson1, P Kirdeikis, R Lastiwka, L Zuk, M Jen, M Elias, P Johnston.   

Abstract

Eight healthy volunteers were used to determine the influence of a normal diet (food) versus an isocaloric chemically defined diet (CDD) on the dose of ranitidine infused continuously over 12 hr, required to maintain the intragastric pH > or = 5 or above. The dose of ranitidine used was adjusted by the pH-stat instrument, Gastrojet, and a target pH of 5.0 was selected. The average ranitidine dose was 43.5 mg for food, 28.3 mg for CDD, and 25.7 mg for fasting. Despite the higher dose of ranitidine used with food, the control of pH was lower than the desired and preset value of pH > or = 5: the average mean pH was 3.99 for food, 5.11 for CDD, and 5.75 for fasting. The percentage of time of pH > or = 5 was 32.0% for food, 73.7% for CDD, and 80.1% for fasting. Thus, when persons are fed a normal diet there is a need for higher doses of ranitidine to maintain the gastric pH > or = 5.0. Even with frequent monitoring of intragastric pH with the Gastrojet, there is much greater variability in pH control with food than with CDD or fasting, and the preset and desired pH level was not achieved. This difficulty in achieving desired end points of pH control when switching from a fasting to a fed state needs to be considered when intravenous ranitidine is used to obtain strict control of intragastric pH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505726     DOI: 10.1023/a:1018850908205

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients.

Authors:  P R Hastings; J J Skillman; L S Bushnell; W Silen
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

2.  Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.

Authors:  W L Peterson; C T Richardson
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

3.  Control of gastric pH with cimetidine: boluses versus primed infusions.

Authors:  M J Ostro; J A Russell; S J Soldin; W A Mahon; K N Jeejeebhoy
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

4.  The prevention and management of stress ulcers.

Authors:  W Silen
Journal:  Hosp Pract       Date:  1980-03

5.  Use of automatic computerised pump to maintain constant intragastric pH.

Authors:  A Hannan; I Chesner; H S Merki; S Mann; R P Walt
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

6.  Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.

Authors:  S W Sanders; K N Buchi; J G Moore; A L Bishop
Journal:  Clin Pharmacol Ther       Date:  1989-11       Impact factor: 6.875

7.  Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.

Authors:  D W Burget; S G Chiverton; R H Hunt
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.